The NCL Medicines Optimisation Team will be launching the NCL 2025-26 Prescribing Quality Scheme (PQS).

The 2025-26 PQS invests in and promotes high-quality, safe, clinically effective, cost-efficient, evidence-based prescribing and is intended to support the implementation of national and local guidance.

This session will cover the entry criteria, individual markers in more detail, scheme monitoring, resource materials, ScriptSwitch® messages, submission dates and award payment.

The session will be recorded and made available on the GP Website.